日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting Polyamine Metabolism in Colorectal Cancer: Apigenin Dismantles the HIF-1α/SMOX Positive Feedback Loop to Suppress Tumor Progression

靶向多胺代谢治疗结直肠癌:芹菜素通过破坏HIF-1α/SMOX正反馈环路抑制肿瘤进展

Zhang, Zhengkun; Xiang, Bin; Geng, Ruiman; Ji, Xuxu; Wang, Dingxue; Yin, Zhaoru; Chen, Lihong; Liu, Ji

Single-cell RNA sequencing defines prognostic subtypes and identifies AIF1L as a therapeutic target in colorectal cancer

单细胞RNA测序可确定预后亚型,并将AIF1L鉴定为结直肠癌的治疗靶点。

Li, Gao; Wang, Dingxue; Chen, Guo

miR-145-5p regulates hepatocellular carcinoma malignant advancement and immune escape via down-regulation of AcylCoA synthase ACSL4.

miR-145-5p 通过下调酰基辅酶A合成酶 ACSL4 来调节肝细胞癌的恶性进展和免疫逃逸

Wang Dingxue, Huang Wenqi, Li Gao

LncRNA SNHG9 is Downregulated in Non-Small Cell Lung Cancer and Suppressed miR-21 Through Methylation to Promote Cell Proliferation

LncRNA SNHG9在非小细胞肺癌中表达下调,并通过甲基化抑制miR-21以促进细胞增殖

Wang, Dingxue; Cao, Xiaoqing; Han, Yi; Yu, Daping

Abnormal Activations of Super-Enhancers Enhance the Carcinogenicity in Lung Adenocarcinoma

超级增强子的异常激活增强了肺腺癌的致癌性

Zhou, Jianlong; Wang, Dingxue; Tang, Dongxin; Huang, Wenhua

Study on the Mechanism of Cell Cycle Checkpoint Kinase 2 (CHEK2) Gene Dysfunction in Chemotherapeutic Drug Resistance of Triple Negative Breast Cancer Cells.

细胞周期检查点激酶2(CHEK2)基因功能障碍在三阴性乳腺癌细胞化疗耐药机制中的研究

Luo Li, Gao Wei, Wang Jinghui, Wang Dingxue, Peng Xiaobo, Jia Zhaoyang, Jiang Ye, Li Gongzhuo, Tang Dongxin, Wang Yajie